MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
711 those areas susceptible to neurofibrillary degeneration (hippocampus and frontal and temporal cortex) had a significantly
aluminium concentration (r
Suggest Documents
Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical sub-types?
BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD).
Comment: Age effects on clinical trial results in Alzheimer dementia.
Vasodilators in senile dementia.
Vasodilators in senile dementia.
Abnormal EEG slow activity in left temporal areas in senile dementia of the Alzheimer type.
Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.
Correlation between mini-mental state examination and quantitative electroencephalography in senile dementia of Alzheimer type.
Levodopa in senile dementia.
Vasodilators in senile dementia.
Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia.
Vasodilators in senile dementia.
Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
Depression and senile dementia of the Alzheimer type: a role for moclobemide.
Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention.
Mild senile dementia of the Alzheimer type: 3. Longitudinal and cross-sectional assessment.
Cerebral vasoreactivity in senile dementia.
Cholinergic involvement in senile dementia.
Trial of levodopa in senile dementia.
Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type.
Use of computerized tomography in senile dementia.
Senile dementia: treatment with deanol.
Clinical effects of choline in Alzheimer senile dementia.
711 those areas susceptible to neurofibrillary degeneration (hippocampus and frontal and temporal cortex) had a significantly aluminium concentration...
162KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical sub-types?
BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD).
Comment: Age effects on clinical trial results in Alzheimer dementia.
Vasodilators in senile dementia.
Vasodilators in senile dementia.
Abnormal EEG slow activity in left temporal areas in senile dementia of the Alzheimer type.
Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.
Correlation between mini-mental state examination and quantitative electroencephalography in senile dementia of Alzheimer type.
Levodopa in senile dementia.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
